Home/Filings/4/0001225208-20-003802
4//SEC Filing

ROGERS DAWN 4

Accession 0001225208-20-003802

CIK 0000078003other

Filed

Feb 27, 7:00 PM ET

Accepted

Feb 28, 7:28 PM ET

Size

17.9 KB

Accession

0001225208-20-003802

Insider Transaction Report

Form 4
Period: 2020-02-26
ROGERS DAWN
Executive Vice President
Transactions
  • Exercise/Conversion

    Common Stock

    2020-02-26$34.59/sh+15,097$522,20524,995 total
  • Tax Payment

    Common Stock

    2020-02-26$34.72/sh1,250$43,40023,745 total
  • Tax Payment

    Common Stock

    2020-02-26$36.80/sh11,524$424,08312,221 total
  • Award

    Phantom Stock Units

    2020-02-26+2,37411,192 total
    Common Stock (2,374 underlying)
  • Exercise/Conversion

    Stock Appreciation Rights

    2020-02-2615,0970 total
    Exercise: $34.59From: 2020-02-26Exp: 2020-02-26Common Stock (15,097 underlying)
  • Award

    Stock Appreciation Rights

    2020-02-27+68,99968,999 total
    Exercise: $34.10From: 2025-02-27Exp: 2025-02-27Common Stock (68,999 underlying)
  • Award

    Stock Appreciation Rights

    2020-02-27+59,11759,117 total
    Exercise: $34.10From: 2027-02-27Exp: 2027-02-27Common Stock (59,117 underlying)
Holdings
  • Common Stock

    (indirect: By Rule 16b-3 Plan)
    9,032
Footnotes (9)
  • [F1]The reported transaction constitutes the earn-out of stock appreciation rights (including dividend equivalents thereon).
  • [F2]The reported transaction constitutes the withholding of shares to satisfy tax obligations in connection with earn-out of stock appreciation rights.
  • [F3]The reported transaction constitutes the withholding of shares to cover payment of exercise price in connection with earn-out of stock appreciation rights (including dividend equivalents thereon).
  • [F4]Under the terms of the settlement of the stock appreciation rights the 20-day average of the closing prices of Pfizer common stock ending on the settlement date is used.
  • [F5]Each unit represents one phantom share of common stock.
  • [F6]The reported transaction constitutes the earn-out of Performance Share Awards (including dividend equivalents thereon) which have been deferred into the Pfizer Inc. Deferred Compensation Plan.
  • [F7]The units, held under the Deferred Compensation Plan, are paid in cash following the reporting person's separation from service and may be transferred by the reporting person into an alternative investment account at any time.
  • [F8]The stock appreciation rights, which are subject to certain vesting requirements, will be settled in shares of Pfizer common stock on the fifth anniversary of the date of grant.
  • [F9]The stock appreciation rights, which are subject to certain vesting requirements, will be settled in shares of Pfizer common stock on the seventh anniversary of the date of grant.

Documents

1 file

Issuer

PFIZER INC

CIK 0000078003

Entity typeother

Related Parties

1
  • filerCIK 0001742308

Filing Metadata

Form type
4
Filed
Feb 27, 7:00 PM ET
Accepted
Feb 28, 7:28 PM ET
Size
17.9 KB